Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use

Endocrinological changes that occur with menopause lead to a chronic and progressive condition named vulvar and vaginal atrophy (VVA). This disease is characterized by symptoms such as dryness, dyspareunia, itching, burning, and dysuria. According to recent epidemiological studies, VVA has a high pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cagnacci, Angelo, Xholli, Anjeza, Venier, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959488/
https://www.ncbi.nlm.nih.gov/pubmed/32021117
http://dx.doi.org/10.2147/PPA.S203614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959488/
https://www.ncbi.nlm.nih.gov/pubmed/32021117
http://dx.doi.org/10.2147/PPA.S203614

Ejemplares similares